Cue Biopharma, Inc. (CUE) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cue Biopharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:04.020 Good afternoon, ladies and gentlemen, and welcome to the CUBE Biopharma third quarter 00:00:04.020 -- 00:00:05.991 2023 earnings 00:00:05.991 -- 00:00:07.411 call. 00:00:07.411 -- 00:00:10.532 At this time, all lines are in listen-only mode. 00:00:10.532 -- 00:00:15.254 Following the presentation, we will conduct a question and answer session. 00:00:15.254 -- 00:00:19.615 If at any time during this call you require immediate assistance, please press star zero 00:00:19.615 -- 00:00:21.796 for the operator. 00:00:21.796 -- 00:00:27.487 As a reminder, this call is being recorded today, Thursday, November 9, 2023. 00:00:29.574 -- 00:00:34.798 I would now like to turn over the conference to Dan Passeri, Chief Executive 00:00:34.798 -- 00:00:37.559 Officer. Please go ahead. 00:00:37.559 -- 00:00:40.722 Yeah, thank you, and good afternoon, everyone. 00:00:40.722 -- 00:00:45.805 As a reminder, this presentation and discussion is being recorded and will be available 00:00:45.805 -- 00:00:51.089 on our website for the next 30 days. Also be aware that the slides accompanying 00:00:51.089 -- 00:00:56.032 today's update may be advanced directly by those listening in on the call, and we'll 00:00:56.032 -- 00:00:59.933 notify you of what slide we're on throughout the presentation. 00:00:59.933 -- 00:01:06.495 Joining me on today's call is Dr. Anish Suri, our President, Chief Scientific Officer, 00:01:06.756 -- 00:01:12.359 Dr. Matteo Levesetti, our Chief Medical Officer, and Kerry Ann Millar, 00:01:12.359 -- 00:01:15.340 our Chief Financial Officer. 00:01:15.601 -- 00:01:20.143 As shown on slide number two, the presentation and overview may contain some forward-looking 00:01:20.143 -- 00:01:24.805 statements, and any forward-looking statement mad...